Community nephrology: audit of screening for renal insufficiency in a high risk population

被引:45
作者
Kissmeyer, L [1 ]
Kong, C [1 ]
Cohen, J [1 ]
Unwin, RJ [1 ]
Woolfson, RG [1 ]
Neild, GH [1 ]
机构
[1] UCL, Sch Med, Inst Urol & Nephrol, London W1N 8AA, England
关键词
community; diabetes; hypertension; primary care; proteinuria; renal insufficiency; screening;
D O I
10.1093/ndt/14.9.2150
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. The rate of acceptance onto dialysis programmes has doubled in the past 10 years and is steadily increasing. Early detection and treatment of renal failure slows the rate of progression Is it feasible to screen for patients who are at increased risk of developing renal failure? We have audited primary care records of patients aged 50-75 years who have either hypertension or diabetes, and are therefore considered to be at high risk of developing renal insufficiency. Our aim was to see whether patients had had their blood pressure measured and urine tested for protein within 12 months, and plasma creatinine measured within 24 months. Methods. This was a retrospective study of case notes and computer records in 12 general practices from inner and greater London. A total of 16 855 patients were aged 50-75 years. From this age group, 2693 (15.5%) patients were identified as being either hypertensive or diabetic, or both. Results. Of the 2561 records audited, 1359 (53.1%) contained a plasma creatinine measured within 24 months, and 11% of these (150) had a value > 125 mu mol/l. This equates to a prevalence of renal insufficiency of >110000 patients per million in this group. Forty two patients (28%) had been referred to a nephrologist. Of records audited, 73% contained a blood pressure measurement and 29% contained a test for proteinuria within 12 months. Conclusions. There is a high prevalence of chronic renal insufficiency in hypertensive and diabetic patients. It is feasible to detect renal insufficiency at a primary care level, but an effective system will require computerized databases that code for age, ethnicity, measurement of blood pressure and renal function, as well as diagnoses.
引用
收藏
页码:2150 / 2155
页数:6
相关论文
共 26 条
[1]   RENAL REPLACEMENT THERAPY IN THE UNITED-STATES - DATA FROM THE UNITED-STATES RENAL DATA SYSTEM [J].
AGODOA, LY ;
EGGERS, PW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (01) :119-133
[2]   RENAL PROTECTIVE EFFECT OF ENALAPRIL IN DIABETIC NEPHROPATHY [J].
BJORCK, S ;
MULEC, H ;
JOHNSEN, SA ;
NORDEN, G ;
AURELL, M .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6823) :339-343
[3]   PREVALENCE OF HYPERTENSION IN THE US ADULT-POPULATION - RESULTS FROM THE 3RD NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1991 [J].
BURT, VL ;
WHELTON, P ;
ROCCELLA, EJ ;
BROWN, C ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D .
HYPERTENSION, 1995, 25 (03) :305-313
[4]  
CAIRNS HS, 1994, BRIT J GEN PRACT, V44, P486
[5]   INCIDENCE OF ADVANCED CHRONIC-RENAL-FAILURE AND THE NEED FOR END STAGE RENAL REPLACEMENT TREATMENT [J].
FEEST, TG ;
MISTRY, CD ;
GRIMES, DS ;
MALLICK, NP .
BRITISH MEDICAL JOURNAL, 1990, 301 (6757) :897-900
[6]   RANDOMIZED CONTROLLED TRIAL OF ENALAPRIL AND BETA-BLOCKERS IN NONDIABETIC CHRONIC-RENAL-FAILURE [J].
HANNEDOUCHE, T ;
LANDAIS, P ;
GOLDFARB, B ;
ELESPER, N ;
FOURNIER, A ;
GODIN, M ;
DURAND, D ;
CHANARD, J ;
MIGNON, F ;
SUC, JM ;
GRUNFELD, JP .
BRITISH MEDICAL JOURNAL, 1994, 309 (6958) :833-837
[7]   BIOCHEMICAL INVESTIGATION OF HYPERTENSION [J].
HARVEY, JM ;
BEEVERS, DG .
ANNALS OF CLINICAL BIOCHEMISTRY, 1990, 27 :287-296
[8]  
INNES A, 1992, NEPHROL DIAL TRANSPL, V7, P467
[9]  
JUNGERS P, 1993, NEPHROL DIAL TRANSPL, V8, P1089
[10]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462